What is left atrial appendage occlusion?

Left atrial appendage (LAA) occlusion is a procedure that prevents thrombus formation within the left atrial appendage during atrial fibrillation (AF), thereby reducing the long-term risk of disability or death caused by thromboembolic events in AF patients. Additionally, this minimally invasive treatment eliminates patients’ dependence on long-term oral anticoagulation therapy, offering them a novel therapeutic option. So, what exactly is LAA occlusion? The following section provides answers to this question.

What Is Left Atrial Appendage Occlusion?

LAA occlusion is an effective alternative to pharmacological therapy for preventing stroke and systemic embolism in patients with atrial fibrillation. Long-term use of anticoagulant medications carries risks such as intracranial hemorrhage and bleeding at other sites. In contrast, LAA occlusion is a non-pharmacological intervention—thus avoiding these bleeding complications altogether. In practice, LAA occlusion involves deploying a device resembling an umbrella to seal off the opening of the left atrial appendage—a small, ear-shaped pouch extending from the left atrium. During AF, blood stasis and subsequent thrombus formation occur predominantly within the left atrial appendage; if a thrombus dislodges, it may cause systemic embolism. By sealing the appendage’s ostium, blood flow into the appendage is prevented, thereby eliminating the substrate for thrombus formation. Currently, LAA occlusion represents a highly advanced interventional technique.

Knowledge Expansion: Efficacy of Left Atrial Appendage Occlusion

1. In patients with atrial fibrillation, over 90% of thrombi originate in the left atrial appendage. As the most common persistent arrhythmia, AF affects 0.5%–1.5% of the general population. Furthermore, LAA occlusion has emerged globally as a cutting-edge strategy for stroke prevention in AF patients, effectively reducing both mortality and morbidity rates.

2. LAA occlusion significantly reduces bleeding risk. This innovative, minimally invasive procedure closes the primary site of thrombus formation—the left atrial appendage—in AF patients, thereby lowering their risk of stroke. The left atrial appendage is an ear-shaped, sac-like structure extending from the left atrium and constitutes an integral part of the left atrium.

The above outlines what left atrial appendage occlusion entails. We hope this information proves helpful to you.